oral glp 1 lilly Eli stock soars on encouraging results for daily weight-loss pill The challenge of developing oral

These headwinds have led to a sharp decline in its stock price, raising questions about the long-term impact of its gamble.

Biopharma bigwigs Eli Lilly and Novo Nordisk are upping capacity to meet the rising demands of GLP-1 drugs.

The 2025 Nobel Prize in Physiology or Medicine is awarded to Joel Habener, Svetlana Mojsov, and Jens Juul Holst for their discovery and development of GLP-1based therapeutics, which have revolutionized the treatment of diabetes and obesity worldwide. | 29 comments on LinkedIn

Access GLP-1 shots, injections and weight loss treatment from trusted providers in your area.

Some of the many news media personalities who have publicly talked about using GLP-1 medications for weight loss include Oprah Winfrey and Andy Cohen.

These drugs significantly reduced rates of #coloncancer (16% fewer cases) and #rectalcancer (28% fewer cases), among others like post-menopausal #breastcancer, #endometrialcancer, and #pancreaticcancer